Chad J. Kolean - Feb 22, 2022 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Chief Financial Officer
Signature
/s/ Asher M. Rubin, Attorneyin-fact for Chad Kolean
Stock symbol
CLRB
Transactions as of
Feb 22, 2022
Transactions value $
$0
Form type
4
Date filed
2/24/2022, 04:00 PM
Next filing
Apr 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +150K $0.00 150K Feb 22, 2022 Common Stock 150K $0.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant.